Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Ihab R. Kamel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0511-7796; OpenAlex author ID A5067085754. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
2
Collaborators
70
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 2 papers

Papers 14

  1. Role of volumetric tumor enhancement on CT in predicting overall survival in patients with unresectable pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.clinimag.2024.110365↗
  2. Value of radiomics features extracted from baseline computed tomography images in predicting overall survival in patients with nonsurgical pancreatic ductal ad… Last author DOI 10.1016/j.gassur.2024.101882↗
  3. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. Co-author DOI 10.1001/jamaoncol.2024.1930↗
  4. Predictive role of radiomics features extracted from preoperative cross-sectional imaging of pancreatic ductal adenocarcinoma in detecting lymph node metastasi… Last author DOI 10.1007/s00261-023-03940-y↗
  5. Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreatitis? Last author DOI 10.1016/j.ejrad.2023.110857↗
  6. Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a … Co-author DOI 10.3389/fonc.2023.1250136↗
  7. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia. Co-author DOI 10.1002/jcsm.12621↗
  8. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. Co-author DOI 10.1007/s11605-019-04230-z↗
  9. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Co-author DOI 10.1053/j.gastro.2018.05.035↗
  10. ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jacr.2017.08.050↗
  11. Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcop… Co-author DOI 10.1007/s11605-015-2835-y↗
  12. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Co-author DOI 10.1158/0008-5472.can-14-0734↗
  13. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Co-author DOI 10.1016/j.cgh.2012.11.016↗
  14. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Co-author DOI 10.1136/gutjnl-2012-303108↗

Closest collaborators

The 25 strongest of 70 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mohammad Mirza‐Aghazadeh‐Attari · 3 shared papers, 2023–2025 · strength 0.69
  2. Seyedeh Panid Madani · 3 shared papers, 2023–2025 · strength 0.69
  3. Daniel A. Laheru · 3 shared papers, 2023–2025 · strength 0.69
  4. Michael Goggins · 7 shared papers, 2013–2024 · strength 0.52
  5. Marcia Irene Canto · 6 shared papers, 2013–2024 · strength 0.41
  6. Ralph H. Hruban MD · 6 shared papers, 2013–2024 · strength 0.41
  7. Anne Marie Lennon · 5 shared papers, 2013–2024 · strength 0.38
  8. Alison P. Klein · 4 shared papers, 2014–2024 · strength 0.35
  9. Elliot K. Fishman · 4 shared papers, 2014–2024 · strength 0.35
  10. Amanda L. Blackford · 3 shared papers, 2018–2024 · strength 0.32
  11. Eun Ji Shin · 3 shared papers, 2018–2024 · strength 0.32
  12. Timothy Michael Pawlik · 2 shared papers, 2015–2025 · strength 0.28
  13. Jin Peng He · 2 shared papers, 2020–2024 · strength 0.25
  14. Richard Andrew Burkhart · 2 shared papers, 2020–2024 · strength 0.25
  15. Christopher Lee Wolfgang · 4 shared papers, 2014–2020 · strength 0.23
  16. Matthew John Weiss · 3 shared papers, 2015–2020 · strength 0.20
  17. Sapna Syngal · 2 shared papers, 2013–2024 · strength 0.20
  18. Dung Thi Le · 1 shared paper, 2023 · strength 0.19
  19. Amol Gupta · 1 shared paper, 2023 · strength 0.19
  20. Ana De Jesus‐Acosta · 1 shared paper, 2023 · strength 0.19
  21. Valerie Lee · 1 shared paper, 2023 · strength 0.19
  22. Lei Zheng · 1 shared paper, 2023 · strength 0.19
  23. Michael Jon Pishvaian · 1 shared paper, 2023 · strength 0.19
  24. Richard David Schulick · 3 shared papers, 2013–2020 · strength 0.18
  25. Weinuo Qu · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.